China Pharma Holdings Inc. (AMEX: CPHI) stock fell -3.14% on Friday to $0.09 against a previous-day closing price of $0.09. With 0.55 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.93 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $0.0980 whereas the lowest price it dropped to was $0.0860. The 52-week range on CPHI shows that it touched its highest point at $2.46 and its lowest point at $0.08 during that stretch. Beta for the stock currently stands at 0.93.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CPHI was up-trending over the past week, with a rise of 0.34%, but this was down by -30.33% over a month. Three-month performance dropped to -67.77% while six-month performance fell -71.74%. The stock lost -92.29% in the past year, while it has lost -90.66% so far this year. EPS is expected to grow by 10.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 29.70%.

Float and Shares Shorts:

At present, 32.95 million CPHI shares are outstanding with a float of 32.43 million shares on hand for trading. On Oct 30, 2023, short shares totaled 43750.0, which was 0.38% higher than short shares on Sep 28, 2023. In addition to Ms. Zhilin Li as the firm’s President, CEO, Chairman & Interim CFO, Ms. Huang Na C.F.A. serves as its BOD Secretary & IR Manager.

Institutional Ownership:

Through their ownership of 2.45% of CPHI’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 0.61% of CPHI, in contrast to 0.05% held by mutual funds. As the largest shareholder in CPHI with 0.30% of the stake, Millennium Management LLC holds 96,783 shares worth 96,783. A second-largest stockholder of CPHI, Two Sigma Securities LLC, holds 60,844 shares, controlling over 0.19% of the firm’s shares. Renaissance Technologies LLC is the third largest shareholder in CPHI, holding 30,930 shares or 0.10% stake. With a 0.05% stake in CPHI, the Bridgeway Ultra Small Company Mar is the largest stakeholder. A total of 14,500 shares are owned by the mutual fund manager.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CPHI since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With CPHI analysts setting a high price target of $45.00 and a low target of $45.00, the average target price over the next 12 months is $45.00. Based on these targets, CPHI could surge 49900.0% to reach the target high and rise by 49900.0% to reach the target low. Reaching the average price target will result in a growth of 49900.0% from current levels.

Summary of Insider Activity:

Insiders traded CPHI stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.

Leave a Reply

Your email address will not be published. Required fields are marked *